The study below asses whether mobile compression prescribed post-operatively for TKA and THA patients aids in reduction of thrombosis risk.

A study by Clifford W. Colwell Jr., MD, Mark I. Froimson, MD, Scott D. Anseth, MD, Nicholas J. Giori, MD, PhD, William G. Hamilton, MD, Robert L. Barrack, MD, Knute C. Buehler, MD, Michael A. Mont, MD, Douglas E. Padgett, MD, Pamela A. Pulido, BSN, and C. Lowery Barnes, MD

Abstract

Venous thromboembolic events, either deep venous thrombosis or pulmonary embolism, are important com- plications in patients undergoing knee or hip arthroplasty. The purpose of this study was to evaluate the effectiveness of a mobile compression device (ActiveCare1S.F.T.) with or without aspirin compared with current pharmacological protocols for prophylaxis against venous thromboembolism in patients undergoing elective primary unilateral arthroplasty of a lower-extremity joint.

Results

Venous thromboembolic events, either deep venous thrombosis or pulmonary embolism, are important com- plications in patients undergoing knee or hip arthroplasty. The purpose of this study was to evaluate the effectiveness of a mobile compression device (ActiveCare1S.F.T.) with or without aspirin compared with current pharmacological protocols for prophylaxis against venous thromboembolism in patients undergoing elective primary unilateral arthroplasty of a lower-extremity joint.

This study was published in The Journal of Bone and Joint Surgery.

Modern DVT Prevention

Compression Solutions is a trusted partner helping with safe post-surgical practices and at-home treatment options.